Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Motor Activity 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Lymphoma 11Lymphoma, Follicular 5Leukemia 5Leukemia, Lymphocytic, Chronic, B-Cell 4Breast Neoplasms 4Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Obesity 2Neoplasms 2Hodgkin Disease 2Fatigue 2Cardiotoxicity 2Waldenstrom Macroglobulinemia 1Ventricular Dysfunction, Left 1Urogenital Neoplasms 1Thyroid Neoplasms 1Sarcopenia 1Pulmonary Disease, Chronic Obstructive 1Prostatic Neoplasms 1Parasomnias 1Overweight 1Ovarian Neoplasms 1Non-alcoholic Fatty Liver Disease 1Neoplasms, Plasma Cell 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, B-Cell, Marginal Zone 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1

Interventions

Nebivolol 1Methods 1Exercise 1(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ventricular Dysfunction, Left × Exercise × Lymphoid × Clear all
NCT03850171 2023-02-27

Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study

Insel Gruppe AG, University Hospital Bern

Phase NA Terminated
57 enrolled
BreastLymphoid

Breast Diseases, Breast Neoplasms, Heart Failure, Lymphoma, Motor Activity, Ventricular Dysfunction, Left, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡